APA (7th ed.) Citation

Chen, Y., Wang, Z., Yuan, S., Jiang, T., Huang, Y., Xu, R., . . . Zhao, Q. (2021). POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy. Wiley.

Chicago Style (17th ed.) Citation

Chen, Yan‐Xing, Zi‐Xian Wang, Shu‐Qiang Yuan, Teng‐Jia Jiang, You‐Sheng Huang, Rui‐Hua Xu, Feng Wang, and Qi Zhao. POLE/POLD1 Mutation in Non‐exonuclease Domain Matters for Predicting Efficacy of Immune‐checkpoint‐inhibitor Therapy. Wiley, 2021.

MLA (8th ed.) Citation

Chen, Yan‐Xing, et al. POLE/POLD1 Mutation in Non‐exonuclease Domain Matters for Predicting Efficacy of Immune‐checkpoint‐inhibitor Therapy. Wiley, 2021.